ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE) — all Canadian products
6 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00015202 | ILOSONE 250MG PULVULE 375 | ELI LILLY CANADA INC | Capsule | Oral | ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE) 250 MG | Cancelled Post Market | |
| 00015474 | ILOSONE LIQUID 125MG/5ML | ELI LILLY CANADA INC | Suspension | Oral | ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE) 125 MG | Cancelled Post Market | |
| 00210641 | ILOSONE LIQUID 250MG/5ML | ELI LILLY CANADA INC | Suspension | Oral | ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE) 250 MG | Cancelled Post Market | |
| 00020966 | NOVO-RYTHRO ESTOLATE CAP 250MG | NOVOPHARM LIMITED | Capsule | Oral | ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE) 250 MG | Cancelled Post Market | |
| 00021172 | NOVO-RYTHRO ESTOLATE SUSPENSION | TEVA CANADA LIMITED | Suspension | Oral | ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE) 125 MG | Cancelled Post Market | |
| 00262595 | NOVO-RYTHRO ESTOLATE SUSPENSION | TEVA CANADA LIMITED | Suspension | Oral | ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE) 250 MG | Cancelled Post Market |
Browse other molecules: